Your browser doesn't support javascript.
loading
Disease recidivism after subtotal petrosectomy and ear canal closure.
Macielak, Robert J; Kull, Amanda J; Carlson, Matthew L; Patel, Neil S.
Afiliação
  • Macielak RJ; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, United States of America.
  • Kull AJ; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT, United States of America.
  • Carlson ML; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, United States of America; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, United States of America.
  • Patel NS; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of Utah, Salt Lake City, UT, United States of America. Electronic address: neil.patel@hsc.utah.edu.
Am J Otolaryngol ; 44(2): 103743, 2023.
Article em En | MEDLINE | ID: mdl-36580740
PURPOSE: To describe the presentation, diagnosis, and management of chronic otitis media recidivism after subtotal petrosectomy and ear canal closure (STP). MATERIALS AND METHODS: Patients with temporal bone pathology detected during follow-up after STP were identified in the electronic medical record. Pertinent clinical details regarding surveillance plan, presentation, imaging findings, and revision surgery were collected and analyzed. RESULTS: A total of 10 patients were identified with recurrent or persistent pathology after STP. The median time to detection was 46 months (IQR 24-84). Five patients (50 %) had non-specific symptomatology, 4 patients (40 %) were completely asymptomatic, and 1 patient (10 %) was asymptomatic outside of two instances of mastoiditis with cochlear implant device infection treated with incision and drainage. One patient (10 %) was noted to have proptosis on examination, but no other patients had objective signs of disease at detection of disease recidivism. Nine (90 %) patients had pathology identified on preoperative imaging. All patients underwent revision surgery, with identification of cholesteatoma in 8 cases (80 %) and cholesterol granuloma in 2 cases (20 %). Extensive disease was noted in 6 patients (60 %), all of whom followed-up greater than 3 years from surgery. All patients tolerated revision surgery without complication. CONCLUSIONS: Recidivistic disease often remains clinically silent for extended periods of time after STP. Planned follow-up - with imaging or second look surgery - to facilitate early detection should be considered. Undetected disease recurrence or development may result in morbidity in a proportion of patients if surveillance is not performed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Otite Média / Implantes Cocleares / Colesteatoma da Orelha Média / Implante Coclear / Reincidência Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Am J Otolaryngol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Otite Média / Implantes Cocleares / Colesteatoma da Orelha Média / Implante Coclear / Reincidência Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Am J Otolaryngol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos